Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXA2R | P21731 | 9/20 | 0.37 |
| ▸ | PTGIR | P43119 | 8/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7959853 | 0.89 | TBXA2R (0.40) | TBXA2RPTGIRMEN1KMT2AKDM4C | |
| SCHEMBL7948671 | 0.83 | PTGIR (0.34) | TBXA2RPTGIRP2RX3PTGDR2 | |
| SCHEMBL7963138 | 0.79 | TBXA2R (0.56) | TBXA2RPTGIRMEN1KMT2AKDM4C | |
| SCHEMBL7958632 | 0.79 | TBXA2R (0.44) | TBXA2RPTGIRMEN1KMT2AKDM4C | |
| SCHEMBL7959858 | 0.71 | TBXA2R (0.37) | TBXA2RPTGIRP2RX3PTGDR2 | |
| SCHEMBL7958915 | 0.68 | TBXA2R (0.53) | TBXA2RPTGIRL3MBTL1 | |
| SCHEMBL7958913 | 0.68 | TBXA2R (0.53) | TBXA2RPTGIRL3MBTL1 | |
| SCHEMBL7963142 | 0.66 | PTGIR (0.48) | TBXA2RPTGIRP2RX3PTGDR2 | |
| SCHEMBL7956565 | 0.65 | MEN1 (0.39) | TBXA2RPTGIRMEN1KMT2AKDM4C | |
| SCHEMBL7958633 | 0.65 | TBXA2R (0.40) | TBXA2RPTGIRP2RX3PTGDR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6323235-B1 | CARDIOVASCULAR DISORDERS, ANTIISCHEMIC AGENTS AND ENZYME INHIBITORS | OHTAKE ATSUSHI (JP) | 2001-11-27 | — | — | US | disclosed |
| US-6043264-A | A THROMBOXANE A2 RECEPTOR ANTAGONIST FOR TREATING HYPERTENSION, THROMBOSIS, ISCHEMIC HEART DISEASES, CIRCULATORY DISEASES, ARTERIOSCLEROSIS, PLATELET FUNCTION DISORDER, HYPERLIPIDEMIA, NEPHRITIS OR ASTHMA | TORAY INDUSTRIES, INC. (JP) | 2000-03-28 | — | — | US | disclosed |
| EP-0751126-A1 | BENZENE-FUSED HETEROCYCLIC DERIVATIVE AND USE OF THE SAME | TORAY INDUSTRIES, INC. (JP) | 1997-01-02 | — | — | EP | disclosed |